Metraipolis › archive › dc_779c1da1f0cb
Real-World Efficacy and Safety of Gemcitabine, Cisplatin, Plus Immune Checkpoint Inhibitors in Biliary Tract Cancer: A Retrospective Analysis — Europe PMC PMID:42649870
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42649870
- DOI
- 10.3390/cancers18162555
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T22:30:48.408Z
- SHA-256 of the archived text
73d853d417bfe87866aafde4d7e2b999a9f8a56517d576f9f214c30eb583b20e- Stable URL of this page
https://metraipolis.com/documento/dc_779c1da1f0cb
How to cite
Real-World Efficacy and Safety of Gemcitabine, Cisplatin, Plus Immune Checkpoint Inhibitors in Biliary Tract Cancer: A Retrospective Analysis — Europe PMC PMID:42649870 — Europe PMC (en), https://europepmc.org/article/MED/42649870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_779c1da1f0cb (Metraipolis archive dc_779c1da1f0cb, sha256 73d853d417bfe87866aafde4d7e2b999a9f8a56517d576f9f214c30eb583b20e)
BibTeX
@misc{dc779c1da1f0cb,
title = {Real-World Efficacy and Safety of Gemcitabine, Cisplatin, Plus Immune Checkpoint Inhibitors in Biliary Tract Cancer: A Retrospective Analysis — Europe PMC PMID:42649870},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42649870},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_779c1da1f0cb; sha256 73d853d417bfe87866aafde4d7e2b999a9f8a56517d576f9f214c30eb583b20e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42649870. Agents can read the archived copy with the MCP tool read_document.